This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.
AVITA Medical Announces FDA Approval of the RECELL® System for the Treatment of Severe Burns in the U.S.
AVITA Medical, a global regenerative medicine company, announced that the U.S. Food and Drug Administration (FDA) approved the Company’s Premarket Approval (PMA) application to market the RECELL® Autologous Cell Harvesting Device
